the potential of caplacizumab in the treatment of attp
Published 6 months ago • 78 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
1:33
real-world multicenter study of caplacizumab in patients with acquired ttp
-
2:43
the management of advanced phase mpns
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
0:57
the potential of the tsafinder tool in hematological oncology
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
2:41
israeli company on the edge of finding diabetes cure
-
9:16
protrombin time (pt) & activated partial tromboplastin time (aptt)|coagulation analyzer|wila djami
-
45:50
treating persistent/chronic itp current care, future potential
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
3:10
the potential for early identification of relapse in dlbcl using serial ctdna sampling
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
8:57
outcomes of sct in t-all and t-lbl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
3:47
a new form of inherited thrombocytopenia: etv6, never judge a book by its cover